Artera Receives CE Marks for AI-Powered Prostate and Breast Cancer Tests
Artera has received CE marks under EU IVDR for its AI-powered prostate and breast cancer assays, enabling clinical use of these prognostic and predictive tests in the European Union and other territories, the company announced.